Colitis  >>  GSK1399686  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
GSK1399686 / GSK
NCT01036022: Effect of GSK1399686 in Patients With Mild to Moderately Active Ulcerative Colitis

Completed
2
120
Canada, Europe
GSK1399686
GlaxoSmithKline
Colitis, Ulcerative
01/13
01/13

Download Options